ES2068154A1 - New analgesic formulations with a broad spectrum of action - Google Patents

New analgesic formulations with a broad spectrum of action

Info

Publication number
ES2068154A1
ES2068154A1 ES09301571A ES9301571A ES2068154A1 ES 2068154 A1 ES2068154 A1 ES 2068154A1 ES 09301571 A ES09301571 A ES 09301571A ES 9301571 A ES9301571 A ES 9301571A ES 2068154 A1 ES2068154 A1 ES 2068154A1
Authority
ES
Spain
Prior art keywords
formulations
new
action
broad spectrum
analgesic formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301571A
Other languages
Spanish (es)
Other versions
ES2068154B1 (en
Inventor
Molina Ramon Gallo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industrial Farmaceutica Cantabria SA
Original Assignee
Industrial Farmaceutica Cantabria SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industrial Farmaceutica Cantabria SA filed Critical Industrial Farmaceutica Cantabria SA
Priority to ES9301571A priority Critical patent/ES2068154B1/en
Publication of ES2068154A1 publication Critical patent/ES2068154A1/en
Application granted granted Critical
Publication of ES2068154B1 publication Critical patent/ES2068154B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

New analgesic formulations with a broad spectrum of action. New liquid analgesic formulations for oral use, suitable for the systemic treatment of pain, are described. Said formulations contain an opioid agonist together with an inert support which operates by controlling the release of the active principle over time. These new formulations contain the following quantities of ingredients per 100 ml of total volume: total morphine hydrochloride: 1.5-3 g standardized phytocolloid: 1.25-1.75 g. These formulations have applications in the pharmaceutical industry.
ES9301571A 1993-07-13 1993-07-13 NEW ANALGESIC FORMULATIONS WITH WIDE INTERVAL OF ACTION. Expired - Fee Related ES2068154B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301571A ES2068154B1 (en) 1993-07-13 1993-07-13 NEW ANALGESIC FORMULATIONS WITH WIDE INTERVAL OF ACTION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301571A ES2068154B1 (en) 1993-07-13 1993-07-13 NEW ANALGESIC FORMULATIONS WITH WIDE INTERVAL OF ACTION.

Publications (2)

Publication Number Publication Date
ES2068154A1 true ES2068154A1 (en) 1995-04-01
ES2068154B1 ES2068154B1 (en) 1995-11-16

Family

ID=8282538

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301571A Expired - Fee Related ES2068154B1 (en) 1993-07-13 1993-07-13 NEW ANALGESIC FORMULATIONS WITH WIDE INTERVAL OF ACTION.

Country Status (1)

Country Link
ES (1) ES2068154B1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
EP0171742A2 (en) * 1984-08-10 1986-02-19 E.I. Du Pont De Nemours And Company Transdermal delivery of opioids
ES8608890A1 (en) * 1985-09-16 1986-09-01 Carulla Vekar S A Liquid pharmaceutical preparation based on theophylline with a retarding effect, and process for producing it.
EP0300806A1 (en) * 1987-07-24 1989-01-25 Vestar, Inc. Opioid analgesic liposomal delivery-release system
WO1992000732A1 (en) * 1990-07-04 1992-01-23 Kabi Pharmacia Ab Therapeutical composition and process for its preparation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
EP0171742A2 (en) * 1984-08-10 1986-02-19 E.I. Du Pont De Nemours And Company Transdermal delivery of opioids
ES8608890A1 (en) * 1985-09-16 1986-09-01 Carulla Vekar S A Liquid pharmaceutical preparation based on theophylline with a retarding effect, and process for producing it.
EP0300806A1 (en) * 1987-07-24 1989-01-25 Vestar, Inc. Opioid analgesic liposomal delivery-release system
WO1992000732A1 (en) * 1990-07-04 1992-01-23 Kabi Pharmacia Ab Therapeutical composition and process for its preparation

Also Published As

Publication number Publication date
ES2068154B1 (en) 1995-11-16

Similar Documents

Publication Publication Date Title
MY112915A (en) Multiple unit tableted dosage form 1
GB2265088B (en) Electrochemical device for drug delivery
HU9600572D0 (en) Medicament for inhibiting gastric acid secretion, multiple unit tablated dosage form
MX9706449A (en) Pharmaceutical composition for piperidinoalkanol compounds.
MX9602683A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
GEP20043203B (en) EP4 Receptor Selective Agonists in the Treatment of Osteoporosis
MY128809A (en) Pharmaceutical formulation of omeprazole
CA2398893A1 (en) Improvements in and relating to controlling drug delivery apparatus
CA2017883A1 (en) Medicament inhalation device and formulation
IL89748A (en) Pharmaceutical compositions for systemic transdermal administration, containing deprenyl
MA26516A1 (en) TARTRATE OF A SUBSTITUTED DIPEPTIDE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
NZ319531A (en) An analgesic synergistic composition containing a sub-analgesic dose of a mu opioid agonist and a kappa-2 opiod agonist
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
AU2084801A (en) Antiviral medication
JO2506B1 (en) A device for the administration of pressurized metered dose aerosols in hydrofluoroalkane propelants
MX9708394A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation.
AU6100194A (en) Active drug delivery device, electrode, and method for making same
PL348202A1 (en) Pharmaceutically active composition and dispensing device
ES2068154A1 (en) New analgesic formulations with a broad spectrum of action
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
NZ508325A (en) Microemulsion preconcentrates for oral administration containing a piperidine substance P antagonist
HK1001822A1 (en) Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride
AU1305999A (en) (+)-ephedrine as a sympathomimetic drug
JO1881B1 (en) Multiple unit tableted dosage from ii
JO1821B1 (en) New phamaceutical formulation

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040601